NetworkNewsBreaks – Avricore Health Inc.’s (TS
Post# of 61
(Total Views: 218)
Posted On: 10/20/2021 2:40:32 PM
NetworkNewsBreaks – Avricore Health Inc.’s (TSX.V: AVCR) (OTCQB: AVCRF) HealthTab(TM) Platform Helping Reduce Patient Care Costs, Waiting Time
Avricore Health (TSX.V: AVCR) (OTCQB: AVCRF) understands that up to 70% of all medical decisions are based on lab tests, which account for between 3% and 6% of total patient-care costs. The amount can be even more significant if a patient requires multiple tests or if the initial test proves unforthcoming. Avricore — which is focused on developing a network of point-of-care analyzers, offering advanced technologies that aid with easy, fast and efficient diagnosis — utilizes its HealthTab(TM) platform in community pharmacies, rural areas and workplaces to cut down on the time it takes for a patient to get a proper diagnosis and medication for their ailment. The company understands the importance of proper and efficient disease diagnosis, hence its investment in point-of-care analyzers. “POC testing has proven to offer the highest cost savings, which can be traced down to the decreased cost of waiting for results,” reads a recent article. “With rapid turnaround times, patients can save between 8-20% of lab costs… With POC testing, as Avricore is currently offering, waiting can improve by as much as 46 minutes per patient, resulting in monetary savings.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
Avricore Health (TSX.V: AVCR) (OTCQB: AVCRF) understands that up to 70% of all medical decisions are based on lab tests, which account for between 3% and 6% of total patient-care costs. The amount can be even more significant if a patient requires multiple tests or if the initial test proves unforthcoming. Avricore — which is focused on developing a network of point-of-care analyzers, offering advanced technologies that aid with easy, fast and efficient diagnosis — utilizes its HealthTab(TM) platform in community pharmacies, rural areas and workplaces to cut down on the time it takes for a patient to get a proper diagnosis and medication for their ailment. The company understands the importance of proper and efficient disease diagnosis, hence its investment in point-of-care analyzers. “POC testing has proven to offer the highest cost savings, which can be traced down to the decreased cost of waiting for results,” reads a recent article. “With rapid turnaround times, patients can save between 8-20% of lab costs… With POC testing, as Avricore is currently offering, waiting can improve by as much as 46 minutes per patient, resulting in monetary savings.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
(0)
(0)Avricore Health Inc. (AVCRF) Stock Research Links
Scroll down for more posts ▼